awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34742904-6165C038-0C82-419F-85B1-BF074D5E7B23
Q34742904-6165C038-0C82-419F-85B1-BF074D5E7B23
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34742904-6165C038-0C82-419F-85B1-BF074D5E7B23
Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.
P2860
Q34742904-6165C038-0C82-419F-85B1-BF074D5E7B23
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34742904-6165C038-0C82-419F-85B1-BF074D5E7B23
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3b4ec619627315b152c8abb5cf07f38589a7bb6c
P2860
APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.